Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

Quest Diagnostics Incorporated (NYSE:DGX), a prominent provider of diagnostic testing and information services, has hit a record-breaking share price of $180.11, pushing the company’s market ...